VAERS reports by lot

GSK Varicella/Shingles lot 353S5: VAERS reports

43 VAERS reports list lot 353S5 as a GSK Varicella/Shingles vaccine, received between 2019-02-02 and 2026-04-22. Data: VAERS public files through 28 May 2026 (site extract 2026-10-28).

Read this first. VAERS accepts reports from anyone, and a report does not establish that the vaccine caused the event. A lot's report count mostly reflects how many doses it contained, when it was used and who received it; no administered-dose counts are published for this lot, so counts are not rates and cannot rank lots against each other. Lot numbers in VAERS reports are typed by reporters and are sometimes wrong.
43
Reports
5%
Marked serious
0
With a death outcome
9
Months with reports

Symptom categories in these reports

A report can mention several categories, so the counts add up to more than the number of reports.

CategoryCount%
General / Systemic (non-local)4425%
Injection-site / Local reaction4123%
Neurological1911%
Musculoskeletal1810%
Dermatological (non-injection-site)1710%
Cardiac / Cardiovascular159%
Gastrointestinal137%
Allergic / Anaphylactic42%
Respiratory32%
Psychiatric / Neuropsychiatric11%

Where reports came from

U.S. state of the reporter, where given (top 12).

StateReports
Missouri6
California4
Oregon4
Texas3
Wisconsin3
Michigan2
New Jersey2
Tennessee2
Washington2
Pennsylvania2
South Carolina1
Kentucky1

Reports by month received

MonthReportsBar
2019-0216
2019-039
2019-046
2019-055
2019-072
2019-091
2019-102
2019-111
2026-041

Products recorded with this lot

Manufacturer and product as reported in VAERS. Reports listing the lot under more than one product are counted once.

Related

Nearby GSK Varicella/Shingles lots (A–Z): 3374S · 34EC5 · 34L52 · 3553N · 35A77 · 35RB7

Source: VAERS public data (CDC/FDA), grouped by manufacturer and lot by the Open Source Medicine Foundation; extract 2026-10-28 18:08 UTC. Not medical advice. Report errors via contact.